TRCT
SKIN icon

Tower Research Capital (TRC)’s SkinHealth Systems SKIN Stock Holding History

Tower Research Capital (TRC)’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.22K Sell
6,098
-23,330
-79% -$17.8K ﹤0.01% 4417
2026
Q1 		$26.2K Buy
29,428
+21,404
+267% +$26.3K ﹤0.01% 3286
2025
Q4 		$11.2K Sell
8,024
-3,920
-33% -$5.67K ﹤0.01% 3642
2025
Q3 		$23.8K Buy
11,944
+1,616
+16% +$3.28K ﹤0.01% 3149
2025
Q2 		$19.7K Buy
10,328
+213
+2% +$300 ﹤0.01% 3688
2025
Q1 		$13.6K Buy
10,115
+3,597
+55% +$5.49K ﹤0.01% 3353
2024
Q4 		$10.4K Sell
6,518
-4,299
-40% -$6.75K ﹤0.01% 3809
2024
Q3 		$15.6K Sell
10,817
-515
-5% -$844 ﹤0.01% 3408
2024
Q2 		$21.8K Buy
11,332
+8,670
+326% +$24.4K ﹤0.01% 3709
2024
Q1 		$11.8K Sell
2,662
-6,089
-70% -$19.8K ﹤0.01% 3529
2023
Q4 		$27.2K Sell
8,751
-3,440
-28% -$12.9K ﹤0.01% 3475
2023
Q3 		$73.4K Buy
12,191
+5,525
+83% +$38.8K ﹤0.01% 2229
2023
Q2 		$55.8K Buy
6,666
+4,217
+172% +$43.8K ﹤0.01% 2498
2023
Q1 		$31K Sell
2,449
-530
-18% -$6.13K ﹤0.01% 2969
2022
Q4 		$27K Sell
2,979
-37,013
-93% -$400K ﹤0.01% 2852
2022
Q3 		$472K Buy
39,992
+32,720
+450% +$414K 0.01% 1192
2022
Q2 		$93K Sell
7,272
-1,577
-18% -$21.1K ﹤0.01% 2355
2022
Q1 		$150K Buy
8,849
+3,537
+67% +$58.4K ﹤0.01% 1946
2021
Q4 		$129K Sell
5,312
-3,639
-41% -$93.8K ﹤0.01% 2062
2021
Q3 		$232K Sell
8,951
-6,180
-41% -$136K 0.01% 1678
2021
Q2 		$254K Buy
+15,131
New +$207K 0.01% 1744

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s SKIN Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its SkinHealth Systems (SKIN) stake by 79% in Q2 2026, selling an estimated $17.8K and leaving 6,098 shares worth $4.22K. The position accounts for ﹤0.01% of the portfolio, ranked #4417.

Tower Research Capital (TRC) first reported a position in SKIN in Q2 2021 and has held it in 21 quarters since. The position peaked at $472K in Q3 2022. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Tower Research Capital (TRC) held 6,098 shares of SkinHealth Systems worth $4.22K as of Q2 2026.
  • Tower Research Capital (TRC) sold 23,330 SkinHealth Systems shares in Q2 2026, an estimated $17.8K.
  • SkinHealth Systems made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4417 holding.
  • Tower Research Capital (TRC) first reported a position in SkinHealth Systems in Q2 2021 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s SkinHealth Systems position peaked at $472K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.